
CureDuchenne Raises $50M to Find Cure for Boys With DMD
A nonprofit that's helped bring six treatments to market just launched a powerful birthday-themed campaign to close the funding gap on a cure for Duchenne muscular dystrophy. The disease still cuts lives tragically short, but CureDuchenne is fighting to change that reality.
For families with sons who have Duchenne muscular dystrophy, every birthday candle carries both celebration and heartbreak.
CureDuchenne just launched "A Cure Can't Wait," a national campaign that shows what birthdays look like as this devastating muscle disease progresses. The nonprofit has already raised over $50 million in its 20-year history and supported research behind six of the eight FDA-approved therapies for DMD.
But here's the problem: those treatments slow the disease, not stop it. That's not good enough for the 300,000 people worldwide living with DMD, most of them boys who historically haven't lived past their 20s.
The campaign follows one child's birthdays from age five through his teenage years as he loses the ability to walk. His mother's voiceover explains the painful reality: "Each birthday is a reminder that the clock is ticking, and I will outlive my child." The final scene shows her standing alone with a birthday cake.
The nonprofit dedicated the campaign to Andrien Joshua Quintero, a 23-year-old DMD patient who appeared in the PSA because he believed awareness could change lives. Quintero passed away in May, shortly after filming.

The Ripple Effect
CureDuchenne's investment of $28 million in scientific research has already transformed treatment. The organization helped develop clinical trials for Elevidys, the first FDA-approved DMD therapy in 2016, very early in its development.
Now new hope is emerging. Recent phase 1 trials of an experimental drug called SAT-3247 show promise that could "re-imagine the therapeutic landscape" for DMD patients, according to analysts.
Horizon Media is donating media placement services to spread the campaign across broadcast, radio, streaming platforms and billboards nationwide. "We believe that media has the power to move people," said CEO Bill Koenigsberg.
Founder and CEO Debra Miller, herself a mother, explained what drives the urgency: "What stands between today's research and tomorrow's cure is funding, and we're calling on the public to join us in closing that gap."
Every donation brings families one step closer to celebrating birthdays without counting down.
Based on reporting by Google News - Disease Cure
This story was written by BrightWire based on verified news reports.
Spread the positivity!
Share this good news with someone who needs it

